ARCT vs. ASST
ARCT (Arcturus Therapeutics Holdings Inc.) and ASST (Asset Entities Inc. Class B Common Stock) are both stocks. ARCT operates in Biotechnology (Healthcare), while ASST operates in Internet Content & Information (Communication Services). Over the past 3 years, ARCT returned -37.62%/yr vs -56.18%/yr for ASST. At a 0.13 correlation, their price movements are largely independent.
Performance
ARCT vs. ASST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARCT achieves a 13.70% return, which is significantly higher than ASST's 2.64% return.
ARCT
- 1D
- 0.00%
- 1M
- -6.69%
- YTD
- 13.70%
- 6M
- -6.57%
- 1Y
- -43.70%
- 3Y*
- -37.62%
- 5Y*
- -27.33%
- 10Y*
- —
ASST
- 1D
- 3.91%
- 1M
- -9.77%
- YTD
- 2.64%
- 6M
- -12.25%
- 1Y
- -86.92%
- 3Y*
- -56.18%
- 5Y*
- —
- 10Y*
- —
ARCT vs. ASST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
ARCT Arcturus Therapeutics Holdings Inc. | 13.70% | -63.88% | -46.18% | 37.63% |
ASST Asset Entities Inc. Class B Common Stock | 2.64% | 50.46% | -84.65% | -89.13% |
Correlation
The correlation between ARCT and ASST is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Feb 3, 2023 | 0.13 |
The correlation between ARCT and ASST shifts across timeframes, from 0.11 (3 years) to 0.22 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
ARCT:
$198.09M
ASST:
$933.69M
ARCT:
-$1.81
ASST:
-$25.54
ARCT:
4.10
ASST:
71.38
ARCT:
$46.80M
ASST:
$5.73M
ARCT:
$40.72M
ASST:
-$7.43M
ARCT:
-$84.61M
ASST:
-$304.63M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARCT vs. ASST — Risk / Return Rank
ARCT
ASST
ARCT vs. ASST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Arcturus Therapeutics Holdings Inc. (ARCT) and Asset Entities Inc. Class B Common Stock (ASST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARCT | ASST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.05 | ||
| Sortino ratioReturn per unit of downside risk | +0.69 | ||
| Omega ratioGain probability vs. loss probability | 0.98 | 0.91 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | -0.60 | -0.92 | +0.31 |
| Martin ratioReturn relative to average drawdown | -0.83 | -1.12 | +0.29 |
Loading charts...
Drawdowns
ARCT vs. ASST - Drawdown Comparison
The maximum ARCT drawdown since its inception was -95.23%, roughly equal to the maximum ASST drawdown of -98.78%. Use the drawdown chart below to compare losses from any high point for ARCT and ASST.
Loading charts...
Drawdown Indicators
| ARCT | ASST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.23% | -98.78% | +3.55% |
Max Drawdown (1Y)Largest decline over 1 year | -74.53% | -95.98% | +21.45% |
Max Drawdown (3Y)Largest decline over 3 years | -86.71% | -97.25% | +10.54% |
Max Drawdown (5Y)Largest decline over 5 years | -89.87% | — | — |
Current DrawdownCurrent decline from peak | -94.36% | -97.42% | +3.06% |
Average DrawdownAverage peak-to-trough decline | -73.03% | -90.39% | +17.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 54.00% | 78.47% | -24.47% |
Volatility
ARCT vs. ASST - Volatility Comparison
The current volatility for Arcturus Therapeutics Holdings Inc. (ARCT) is 18.29%, while Asset Entities Inc. Class B Common Stock (ASST) has a volatility of 23.80%. This indicates that ARCT experiences smaller price fluctuations and is considered to be less risky than ASST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARCT | ASST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.29% | 23.80% | -5.51% |
Volatility (6M)Calculated over the trailing 6-month period | 40.18% | 81.69% | -41.51% |
Volatility (1Y)Calculated over the trailing 1-year period | 92.49% | 162.68% | -70.19% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.80% | 322.54% | -230.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 102.11% | 322.54% | -220.43% |
Dividends
ARCT vs. ASST - Dividend Comparison
Neither ARCT nor ASST has paid dividends to shareholders.
Financials
ARCT vs. ASST - Financials Comparison
This section allows you to compare key financial metrics between Arcturus Therapeutics Holdings Inc. and Asset Entities Inc. Class B Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ARCT and ASST have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ASST has higher volatility (23.80%) compared to ARCT (18.29%). In terms of maximum drawdown, ARCT dropped -95.23% vs ASST's -98.78%.
ARCT currently has the higher Sharpe Ratio (-0.49 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARCT and ASST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer